Bermuda
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.52 (0.44 - 0.62) | 2019 | Modelled | IHME |
0.52 (0.44 - 0.61) | 2018 | Modelled | IHME |
0.52 (0.44 - 0.60) | 2017 | Modelled | IHME |
0.52 (0.45 - 0.60) | 2016 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2015 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2014 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2013 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2012 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2011 | Modelled | IHME |
0.53 (0.45 - 0.61) | 2010 | Modelled | IHME |
0.54 (0.46 - 0.62) | 2009 | Modelled | IHME |
0.54 (0.46 - 0.63) | 2008 | Modelled | IHME |
0.55 (0.46 - 0.64) | 2007 | Modelled | IHME |
0.55 (0.47 - 0.64) | 2006 | Modelled | IHME |
0.55 (0.46 - 0.65) | 2005 | Modelled | IHME |
0.55 (0.47 - 0.65) | 2004 | Modelled | IHME |
0.55 (0.46 - 0.64) | 2003 | Modelled | IHME |
0.55 (0.46 - 0.65) | 2002 | Modelled | IHME |
0.55 (0.46 - 0.65) | 2001 | Modelled | IHME |
0.55 (0.45 - 0.65) | 2000 | Modelled | IHME |
0.55 (0.46 - 0.65) | 1999 | Modelled | IHME |
0.56 (0.46 - 0.65) | 1998 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1997 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1996 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1995 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1994 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1993 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1992 | Modelled | IHME |
0.56 (0.47 - 0.65) | 1991 | Modelled | IHME |
0.56 (0.47 - 0.66) | 1990 | Modelled | IHME |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.24 (0.16 - 0.32) | 2019 | Modelled | IHME |
0.23 (0.16 - 0.31) | 2018 | Modelled | IHME |
0.23 (0.17 - 0.31) | 2017 | Modelled | IHME |
0.24 (0.17 - 0.32) | 2016 | Modelled | IHME |
0.24 (0.17 - 0.33) | 2015 | Modelled | IHME |
0.25 (0.17 - 0.33) | 2014 | Modelled | IHME |
0.25 (0.17 - 0.33) | 2013 | Modelled | IHME |
0.25 (0.17 - 0.33) | 2012 | Modelled | IHME |
0.25 (0.17 - 0.33) | 2011 | Modelled | IHME |
0.25 (0.17 - 0.33) | 2010 | Modelled | IHME |
0.25 (0.18 - 0.33) | 2009 | Modelled | IHME |
0.25 (0.18 - 0.34) | 2008 | Modelled | IHME |
0.26 (0.18 - 0.34) | 2007 | Modelled | IHME |
0.26 (0.18 - 0.35) | 2006 | Modelled | IHME |
0.27 (0.18 - 0.36) | 2005 | Modelled | IHME |
0.27 (0.18 - 0.35) | 2004 | Modelled | IHME |
0.27 (0.18 - 0.35) | 2003 | Modelled | IHME |
0.27 (0.18 - 0.35) | 2002 | Modelled | IHME |
0.26 (0.18 - 0.35) | 2001 | Modelled | IHME |
0.26 (0.18 - 0.36) | 2000 | Modelled | IHME |
0.27 (0.18 - 0.36) | 1999 | Modelled | IHME |
0.27 (0.19 - 0.36) | 1998 | Modelled | IHME |
0.27 (0.19 - 0.36) | 1997 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1996 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1995 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1994 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1993 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1992 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1991 | Modelled | IHME |
0.27 (0.19 - 0.37) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
332 (277 - 390) | 1990 | Modelled | IHME |
335 (282 - 390) | 1991 | Modelled | IHME |
337 (285 - 391) | 1992 | Modelled | IHME |
339 (286 - 392) | 1993 | Modelled | IHME |
342 (288 - 395) | 1994 | Modelled | IHME |
344 (287 - 399) | 1995 | Modelled | IHME |
346 (291 - 400) | 1996 | Modelled | IHME |
347 (291 - 402) | 1997 | Modelled | IHME |
348 (290 - 405) | 1998 | Modelled | IHME |
349 (289 - 407) | 1999 | Modelled | IHME |
351 (287 - 411) | 2000 | Modelled | IHME |
352 (291 - 412) | 2001 | Modelled | IHME |
354 (294 - 413) | 2002 | Modelled | IHME |
356 (297 - 413) | 2003 | Modelled | IHME |
358 (300 - 416) | 2004 | Modelled | IHME |
359 (300 - 420) | 2005 | Modelled | IHME |
359 (302 - 416) | 2006 | Modelled | IHME |
356 (302 - 414) | 2007 | Modelled | IHME |
353 (301 - 408) | 2008 | Modelled | IHME |
350 (299 - 404) | 2009 | Modelled | IHME |
348 (296 - 402) | 2010 | Modelled | IHME |
347 (298 - 400) | 2011 | Modelled | IHME |
346 (296 - 399) | 2012 | Modelled | IHME |
345 (295 - 397) | 2013 | Modelled | IHME |
343 (294 - 396) | 2014 | Modelled | IHME |
342 (292 - 395) | 2015 | Modelled | IHME |
339 (290 - 390) | 2016 | Modelled | IHME |
336 (283 - 390) | 2017 | Modelled | IHME |
335 (283 - 389) | 2018 | Modelled | IHME |
335 (281 - 394) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
2.36 (1.76 - 3.13) | 2019 | Modelled | IHME |
2.33 (1.74 - 3.07) | 2018 | Modelled | IHME |
2.29 (1.70 - 3) | 2017 | Modelled | IHME |
2.26 (1.70 - 2.95) | 2016 | Modelled | IHME |
2.2 (1.67 - 2.84) | 2015 | Modelled | IHME |
2.14 (1.64 - 2.76) | 2014 | Modelled | IHME |
2.07 (1.61 - 2.65) | 2013 | Modelled | IHME |
2.02 (1.57 - 2.58) | 2012 | Modelled | IHME |
1.97 (1.54 - 2.54) | 2011 | Modelled | IHME |
1.97 (1.52 - 2.54) | 2010 | Modelled | IHME |
1.93 (1.50 - 2.49) | 2009 | Modelled | IHME |
1.91 (1.48 - 2.47) | 2008 | Modelled | IHME |
1.88 (1.46 - 2.43) | 2007 | Modelled | IHME |
1.88 (1.47 - 2.46) | 2006 | Modelled | IHME |
1.87 (1.46 - 2.42) | 2005 | Modelled | IHME |
1.86 (1.45 - 2.42) | 2004 | Modelled | IHME |
1.88 (1.45 - 2.43) | 2003 | Modelled | IHME |
1.89 (1.47 - 2.42) | 2002 | Modelled | IHME |
1.92 (1.48 - 2.46) | 2001 | Modelled | IHME |
2.01 (1.54 - 2.59) | 2000 | Modelled | IHME |
2.15 (1.66 - 2.74) | 1999 | Modelled | IHME |
2.29 (1.78 - 2.91) | 1998 | Modelled | IHME |
2.5 (1.95 - 3.14) | 1997 | Modelled | IHME |
2.84 (2.21 - 3.57) | 1996 | Modelled | IHME |
3.04 (2.37 - 3.79) | 1995 | Modelled | IHME |
3.29 (2.55 - 4.10) | 1994 | Modelled | IHME |
3.48 (2.72 - 4.35) | 1993 | Modelled | IHME |
3.57 (2.79 - 4.44) | 1992 | Modelled | IHME |
3.77 (2.95 - 4.72) | 1991 | Modelled | IHME |
3.84 (3.01 - 4.82) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2 (1 - 2) | 2019 | Modelled | IHME |
2 (1 - 2) | 2018 | Modelled | IHME |
1 (1 - 2) | 2017 | Modelled | IHME |
1 (1 - 2) | 2016 | Modelled | IHME |
1 (1 - 2) | 2015 | Modelled | IHME |
1 (1 - 2) | 2014 | Modelled | IHME |
1 (1 - 2) | 2013 | Modelled | IHME |
1 (1 - 2) | 2012 | Modelled | IHME |
1 (1 - 2) | 2011 | Modelled | IHME |
1 (1 - 2) | 2010 | Modelled | IHME |
1 (1 - 2) | 2009 | Modelled | IHME |
1 (1 - 2) | 2008 | Modelled | IHME |
1 (1 - 2) | 2007 | Modelled | IHME |
1 (1 - 2) | 2006 | Modelled | IHME |
1 (1 - 2) | 2005 | Modelled | IHME |
1 (1 - 2) | 2004 | Modelled | IHME |
1 (1 - 2) | 2003 | Modelled | IHME |
1 (1 - 2) | 2002 | Modelled | IHME |
1 (1 - 2) | 2001 | Modelled | IHME |
1 (1 - 2) | 2000 | Modelled | IHME |
1 (1 - 2) | 1999 | Modelled | IHME |
1 (1 - 2) | 1998 | Modelled | IHME |
2 (1 - 2) | 1997 | Modelled | IHME |
2 (1 - 2) | 1996 | Modelled | IHME |
2 (1 - 2) | 1995 | Modelled | IHME |
2 (2 - 3) | 1994 | Modelled | IHME |
2 (2 - 3) | 1993 | Modelled | IHME |
2 (2 - 3) | 1992 | Modelled | IHME |
2 (2 - 3) | 1991 | Modelled | IHME |
2 (2 - 3) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
23 (16 - 31) | 2019 | Modelled | IHME |
23 (16 - 31) | 2018 | Modelled | IHME |
23 (16 - 31) | 2017 | Modelled | IHME |
23 (17 - 32) | 2016 | Modelled | IHME |
23 (17 - 32) | 2015 | Modelled | IHME |
23 (17 - 32) | 2014 | Modelled | IHME |
24 (17 - 32) | 2013 | Modelled | IHME |
24 (17 - 32) | 2012 | Modelled | IHME |
24 (17 - 33) | 2011 | Modelled | IHME |
24 (17 - 33) | 2010 | Modelled | IHME |
24 (17 - 33) | 2009 | Modelled | IHME |
24 (17 - 33) | 2008 | Modelled | IHME |
24 (17 - 33) | 2007 | Modelled | IHME |
24 (17 - 32) | 2006 | Modelled | IHME |
24 (17 - 32) | 2005 | Modelled | IHME |
24 (17 - 32) | 2004 | Modelled | IHME |
24 (17 - 32) | 2003 | Modelled | IHME |
23 (17 - 32) | 2002 | Modelled | IHME |
23 (17 - 32) | 2001 | Modelled | IHME |
23 (17 - 32) | 2000 | Modelled | IHME |
24 (17 - 32) | 1999 | Modelled | IHME |
24 (17 - 32) | 1998 | Modelled | IHME |
24 (17 - 32) | 1997 | Modelled | IHME |
24 (17 - 32) | 1996 | Modelled | IHME |
24 (18 - 32) | 1995 | Modelled | IHME |
24 (18 - 32) | 1994 | Modelled | IHME |
24 (18 - 33) | 1993 | Modelled | IHME |
24 (18 - 33) | 1992 | Modelled | IHME |
24 (18 - 33) | 1991 | Modelled | IHME |
24 (18 - 33) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.65 (1.33 - 2.06) | 2019 | Modelled | IHME |
1.64 (1.34 - 2.04) | 2018 | Modelled | IHME |
1.62 (1.33 - 2.02) | 2017 | Modelled | IHME |
1.59 (1.32 - 1.96) | 2016 | Modelled | IHME |
1.56 (1.29 - 1.92) | 2015 | Modelled | IHME |
1.57 (1.29 - 1.93) | 2014 | Modelled | IHME |
1.57 (1.29 - 1.93) | 2013 | Modelled | IHME |
1.57 (1.29 - 1.94) | 2012 | Modelled | IHME |
1.58 (1.29 - 1.96) | 2011 | Modelled | IHME |
1.58 (1.29 - 1.97) | 2010 | Modelled | IHME |
1.59 (1.29 - 1.97) | 2009 | Modelled | IHME |
1.59 (1.30 - 1.96) | 2008 | Modelled | IHME |
1.6 (1.30 - 1.97) | 2007 | Modelled | IHME |
1.61 (1.31 - 1.98) | 2006 | Modelled | IHME |
1.62 (1.32 - 1.99) | 2005 | Modelled | IHME |
1.64 (1.34 - 2) | 2004 | Modelled | IHME |
1.65 (1.35 - 2.03) | 2003 | Modelled | IHME |
1.67 (1.36 - 2.07) | 2002 | Modelled | IHME |
1.69 (1.37 - 2.10) | 2001 | Modelled | IHME |
1.71 (1.38 - 2.10) | 2000 | Modelled | IHME |
1.73 (1.40 - 2.13) | 1999 | Modelled | IHME |
1.74 (1.41 - 2.16) | 1998 | Modelled | IHME |
1.76 (1.42 - 2.18) | 1997 | Modelled | IHME |
1.78 (1.44 - 2.20) | 1996 | Modelled | IHME |
1.79 (1.45 - 2.21) | 1995 | Modelled | IHME |
1.8 (1.46 - 2.23) | 1994 | Modelled | IHME |
1.81 (1.47 - 2.25) | 1993 | Modelled | IHME |
1.82 (1.47 - 2.26) | 1992 | Modelled | IHME |
1.82 (1.48 - 2.28) | 1991 | Modelled | IHME |
1.83 (1.48 - 2.29) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
1,086 (881 - 1,362) | 1990 | Modelled | IHME |
1,091 (886 - 1,363) | 1991 | Modelled | IHME |
1,095 (888 - 1,362) | 1992 | Modelled | IHME |
1,098 (890 - 1,369) | 1993 | Modelled | IHME |
1,099 (891 - 1,364) | 1994 | Modelled | IHME |
1,100 (892 - 1,362) | 1995 | Modelled | IHME |
1,100 (890 - 1,362) | 1996 | Modelled | IHME |
1,097 (886 - 1,358) | 1997 | Modelled | IHME |
1,093 (885 - 1,352) | 1998 | Modelled | IHME |
1,088 (880 - 1,340) | 1999 | Modelled | IHME |
1,083 (875 - 1,333) | 2000 | Modelled | IHME |
1,077 (873 - 1,335) | 2001 | Modelled | IHME |
1,069 (870 - 1,320) | 2002 | Modelled | IHME |
1,062 (864 - 1,306) | 2003 | Modelled | IHME |
1,055 (861 - 1,292) | 2004 | Modelled | IHME |
1,050 (855 - 1,288) | 2005 | Modelled | IHME |
1,047 (852 - 1,288) | 2006 | Modelled | IHME |
1,043 (846 - 1,282) | 2007 | Modelled | IHME |
1,040 (845 - 1,283) | 2008 | Modelled | IHME |
1,038 (844 - 1,285) | 2009 | Modelled | IHME |
1,035 (842 - 1,288) | 2010 | Modelled | IHME |
1,032 (843 - 1,282) | 2011 | Modelled | IHME |
1,028 (843 - 1,272) | 2012 | Modelled | IHME |
1,024 (843 - 1,259) | 2013 | Modelled | IHME |
1,019 (839 - 1,254) | 2014 | Modelled | IHME |
1,016 (837 - 1,249) | 2015 | Modelled | IHME |
1,029 (853 - 1,266) | 2016 | Modelled | IHME |
1,047 (857 - 1,302) | 2017 | Modelled | IHME |
1,054 (864 - 1,312) | 2018 | Modelled | IHME |
1,057 (854 - 1,317) | 2019 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
2.94 (2.13 - 3.96) | 2019 | Modelled | IHME |
2.88 (2.10 - 3.82) | 2018 | Modelled | IHME |
2.83 (2.07 - 3.75) | 2017 | Modelled | IHME |
2.78 (2.06 - 3.68) | 2016 | Modelled | IHME |
2.7 (2.02 - 3.57) | 2015 | Modelled | IHME |
2.62 (1.98 - 3.44) | 2014 | Modelled | IHME |
2.53 (1.95 - 3.33) | 2013 | Modelled | IHME |
2.46 (1.89 - 3.25) | 2012 | Modelled | IHME |
2.41 (1.86 - 3.18) | 2011 | Modelled | IHME |
2.41 (1.86 - 3.19) | 2010 | Modelled | IHME |
2.38 (1.84 - 3.12) | 2009 | Modelled | IHME |
2.37 (1.82 - 3.09) | 2008 | Modelled | IHME |
2.34 (1.80 - 3.07) | 2007 | Modelled | IHME |
2.34 (1.80 - 3.08) | 2006 | Modelled | IHME |
2.34 (1.80 - 3.05) | 2005 | Modelled | IHME |
2.35 (1.81 - 3.05) | 2004 | Modelled | IHME |
2.38 (1.84 - 3.10) | 2003 | Modelled | IHME |
2.43 (1.88 - 3.16) | 2002 | Modelled | IHME |
2.46 (1.90 - 3.20) | 2001 | Modelled | IHME |
2.59 (2.01 - 3.36) | 2000 | Modelled | IHME |
2.74 (2.15 - 3.55) | 1999 | Modelled | IHME |
2.91 (2.27 - 3.73) | 1998 | Modelled | IHME |
3.13 (2.43 - 4.01) | 1997 | Modelled | IHME |
3.5 (2.71 - 4.45) | 1996 | Modelled | IHME |
3.69 (2.88 - 4.66) | 1995 | Modelled | IHME |
3.97 (3.08 - 5.03) | 1994 | Modelled | IHME |
4.16 (3.23 - 5.28) | 1993 | Modelled | IHME |
4.23 (3.30 - 5.37) | 1992 | Modelled | IHME |
4.44 (3.47 - 5.62) | 1991 | Modelled | IHME |
4.54 (3.55 - 5.72) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2 (1 - 3) | 2019 | Modelled | IHME |
2 (1 - 2) | 2018 | Modelled | IHME |
2 (1 - 2) | 2017 | Modelled | IHME |
2 (1 - 2) | 2016 | Modelled | IHME |
2 (1 - 2) | 2015 | Modelled | IHME |
2 (1 - 2) | 2014 | Modelled | IHME |
2 (1 - 2) | 2013 | Modelled | IHME |
2 (1 - 2) | 2012 | Modelled | IHME |
2 (1 - 2) | 2011 | Modelled | IHME |
2 (1 - 2) | 2010 | Modelled | IHME |
2 (1 - 2) | 2009 | Modelled | IHME |
2 (1 - 2) | 2008 | Modelled | IHME |
2 (1 - 2) | 2007 | Modelled | IHME |
2 (1 - 2) | 2006 | Modelled | IHME |
2 (1 - 2) | 2005 | Modelled | IHME |
2 (1 - 2) | 2004 | Modelled | IHME |
2 (1 - 2) | 2003 | Modelled | IHME |
2 (1 - 2) | 2002 | Modelled | IHME |
2 (1 - 2) | 2001 | Modelled | IHME |
2 (1 - 2) | 2000 | Modelled | IHME |
2 (1 - 2) | 1999 | Modelled | IHME |
2 (1 - 2) | 1998 | Modelled | IHME |
2 (2 - 2) | 1997 | Modelled | IHME |
2 (2 - 3) | 1996 | Modelled | IHME |
2 (2 - 3) | 1995 | Modelled | IHME |
2 (2 - 3) | 1994 | Modelled | IHME |
3 (2 - 3) | 1993 | Modelled | IHME |
3 (2 - 3) | 1992 | Modelled | IHME |
3 (2 - 3) | 1991 | Modelled | IHME |
3 (2 - 3) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
23 (16 - 31) | 2019 | Modelled | IHME |
23 (16 - 30) | 2018 | Modelled | IHME |
23 (16 - 30) | 2017 | Modelled | IHME |
23 (16 - 30) | 2016 | Modelled | IHME |
23 (16 - 30) | 2015 | Modelled | IHME |
23 (16 - 30) | 2014 | Modelled | IHME |
22 (16 - 30) | 2013 | Modelled | IHME |
23 (16 - 30) | 2012 | Modelled | IHME |
23 (16 - 30) | 2011 | Modelled | IHME |
22 (16 - 30) | 2010 | Modelled | IHME |
23 (16 - 30) | 2009 | Modelled | IHME |
22 (16 - 30) | 2008 | Modelled | IHME |
22 (16 - 30) | 2007 | Modelled | IHME |
22 (16 - 29) | 2006 | Modelled | IHME |
22 (16 - 30) | 2005 | Modelled | IHME |
22 (16 - 30) | 2004 | Modelled | IHME |
23 (16 - 30) | 2003 | Modelled | IHME |
23 (16 - 30) | 2002 | Modelled | IHME |
23 (16 - 30) | 2001 | Modelled | IHME |
23 (16 - 30) | 2000 | Modelled | IHME |
23 (16 - 30) | 1999 | Modelled | IHME |
23 (16 - 30) | 1998 | Modelled | IHME |
23 (16 - 30) | 1997 | Modelled | IHME |
23 (16 - 31) | 1996 | Modelled | IHME |
23 (16 - 30) | 1995 | Modelled | IHME |
23 (16 - 30) | 1994 | Modelled | IHME |
22 (16 - 30) | 1993 | Modelled | IHME |
22 (15 - 30) | 1992 | Modelled | IHME |
22 (15 - 29) | 1991 | Modelled | IHME |
22 (15 - 30) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.24
(%)
2019, latest modelled
(0.16 - 0.32(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines